Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cells.

Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cells. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cells. Abstract Text:

Rebecca S Henkhaus,Upal Kunal Basu Roy,Dora Cavallo-Medved,Bonnie F Sloane,Eugene W Gerner,Natalia A Ignatenko,Rebecca S Henkhaus,Upal Kunal Basu Roy,Dora Cavallo-Medved,Bonnie F Sloane,Eugene W Gerner,Natalia A Ignatenko,

Kallikreins are secreted proteases that may play a functional role and/or serve as a serum biomarker for the presence or progression of certain types of cancers. Kallikrein 6 (KLK6) has been shown to be upregulated in several types of cancers, including colon. The aims of this study were to elucidate pathways that influence KLK6 gene expression and KLK6 protein secretion in the HCT116 human colon cancer cells. Our data indicate a central role for caveolin-1 (CAV-1), the main structural protein of caveolae, in both KLK6 gene expression and protein secretion. Sucrose gradient subcellular fractionation reveals that CAV-1 and KLK6 colocalize to lipid raft domains in the plasma membrane of HCT116 cells. Furthermore, we show that CAV-1, although it does not directly interact with the KLK6 molecule, enhances KLK6 secretion from the cells. Deactivation of CAV-1, through SRC-mediated phosphorylation, decreased KLK6 secretion. We also demonstrate that, in colon cancer cells, CAV-1 increased the amount of phosphorylated AKT in cells by inhibiting the activity of the AKT-negative regulators PP1 and PP2A. This study demonstrates that proteins such as CAV-1 and AKT, which are known to be altered in colon cancer, affect KLK6 expression and KLK6 secretion.

Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cells. Publishing Authors By Initials

RS Henkhaus,UK Roy,D Cavallo-Medved,BF Sloane,EW Gerner,NA Ignatenko,RS Henkhaus,UK Roy,D Cavallo-Medved,BF Sloane,EW Gerner,NA Ignatenko,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cells. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Neoplasia (New York, N.Y.)

VOLUME: 10

Page Numbers: 140-8

Journal Abbreviation: Neoplasia

ISSN: 1476-5586

DAY: 19

MONTH: Feb

YEAR: 2008

Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cells. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100886622

Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cells. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cells. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cells.

AFFILIATION: Department of Cancer Biology, Arizona Cancer Center, University of Arizona, Tucson, AZ, USA.

Country: Canada

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Neoplasia

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cells Related Publications

• Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cells.
• Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells.
• [Diurnal changes in the duration of mitosis in rats]
• [Effect of immunomodulators of organometallic nature on the sensitivity to plague toxin]
• [Effect of serotonin and histamine on the cellular contractile activity of the internal carotid artery]
• [Effects of glutamic acid and glutathione on the secretory function of the stomach]
• [Interactions of mononuclear cells of peripheral blood with islet cells in vitro]
• [Mechanism of the action of amino acids on gastric secretion]
• [Presence of specific bradykinin receptors in arterial and venous smooth muscle]
• [The role of specific determinants of streptococcus group A polysaccharides in inhibiting the activity of T-suppressors]